A new release of Phase III data in diabetic patients related to Eli Lilly’s orforglipron signals a positive turnaround for ...

In a U-turn from a decision two weeks ago, the FDA – citing new safety events – said the vaccine is a ‘danger to health’.

AbbVie has signed a definitive agreement to acquire Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin, ...

Analysts and charities have identified Gilead’s new HIV prevention injection as key to curbing infection rates ...

Genentech, a member of the Roche Group, has commenced construction of a new manufacturing site in Holly Springs, North ...

We look at how micro- and nano-milling are transforming different sectors and preview Frewitt’s latest innovations.

Daiichi Sankyo and AstraZeneca have received approval from China’s National Medical Products Administration (NMPA) for ...

Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...

Contract development and manufacturing organisation (CDMO) Andelyn Biosciences has entered a collaboration with Amplo ...

Amid a push to phase out animal testing, Charles River’s Steve Bulera notes that the implementation of alternative methods ...

Antibody‑drug conjugates (ADCs) remain an area of extreme focus in the pharmaceuticals space, with the market projected to ...

Every aspect of science and research is based on data, and across the globe, labs are producing more data than the average ...